TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05811364: The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disea

Sponsor: W.L.Gore & Associates · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 244 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,556,400

Rescue Site Savings

+$1,693,200

Unlock Full NCT05811364 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05811364 Rescue Dossier →